Rumour: We are getting reports that GSK, following their announcement reported in the FT on 31st January of a likely 3,000 job cuts globally, are to close their Harlow branch, formerly the Smith Kline Beecham flagship facility, with the likely loss of 2,000 jobs. Workers at the facility were told they would be made redundant on Thursday.
A reminder, if one were needed that, the employees of the junior partner in any ‘merger’ rarely enjoy long term job security. GSK was formed out of the takeover/merger of GlaxoWellcome plc and SmithKline Beecham plc in 2000. Like most pharmaceutical companies, it is reducing its headcount in western markets and focusing on growth in emerging markets.